GL1X · GenesisL1 explorer

MolNFT v1 · #125908 · protein

Discovery of a novel class of highly potent inhibitors of the P53-MDM2 interaction by structure-based design starting from a conformational argument

5LN2 · E3 ubiquitin-protein ligase MDM2: “Discovery of a novel class of highly potent inhibitors of the P53-MDM2 interaction by structure-based design…”. X-ray diffraction, 3 ligands (6ZT, SO4, CL), 1 pocket (best druggability 0.46).…

PDB
5LN2
Type
protein
Length
95 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
E3 ubiquitin-protein ligase MDM2
EC
6.3.2.-
UniProt
Q00987
Ligands
6ZT, SO4, CL
Pockets
1 · best druggability 0.46

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AE3 ubiquitin-protein ligase MDM2 (EC 6.3.2.-)protein9543% helix, 17% strandQ00987

Ligands and binding sites

  • 6ZT · (4~{S})-5-[5-chloranyl-2-[2-(dimethylamino) ethoxy]phenyl]-4-(4-chloranyl-2-methyl-phenyl)-2-(2-methoxyphenyl)-3-propan-2-yl-4~{H}-pyrrolo[3,4-c]pyrazol-6-one · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11250.460.77186ZT

Compared structures

  • 5LN2 · Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.